Target intelligence / Profile preview

Telomerase reverse transcriptase (TERT)

Target
TERT
Molecular classification
Enzyme, Reverse transcriptase, RNA-dependent DNA polymerase, Ribonucleoprotein complex component
01

Overview

Telomerase reverse transcriptase is the catalytic protein subunit essential for the function of the enzyme telomerase, a ribonucleoprotein complex responsible for maintaining chromosome ends by adding repetitive TTAGGG sequences to telomeres. This process is crucial for genome stability during cell division. The enzyme consists primarily of two core components: TERT itself—a specialized reverse transcriptase—and an integral RNA template known as TERC. While most somatic cells repress TERT expression after development—leading to progressive shortening and eventual loss-of-function at chromosomal ends—stem cells, germline cells, and especially cancerous cells often maintain high levels of active hTERT. This enables unlimited replicative potential characteristic of malignancy. Structurally, human TERT contains unique N-terminal and C-terminal extensions flanking a central RT-like domain with conserved motifs required for its enzymatic function. It forms part of a larger holoenzyme complex with additional proteins necessary for biogenesis, localization, recruitment to chromosome ends via shelterin proteins like TPP1, and processive repeat synthesis. Because reactivation or upregulation occurs in over 85%–90% percent of human cancers, telomerase reverse transcriptase is considered an important therapeutic target both experimentally and clinically; several small molecules are under investigation as direct inhibitors. However, systemic inhibition poses risks due to possible adverse effects on normal regenerative tissues.

Other names
TERThTERT (for human telomerase reverse transcriptase)Telomerase catalytic subunitTelomerase RNA-dependent DNA polymerase
02

Mechanism of action

Drugs targeting this molecule typically act by one or more of the following mechanisms: Direct inhibition of the enzymatic activity of TERT/telomerase, preventing addition of TTAGGG repeats to chromosome ends. Disruption of the assembly or stability of the telomerase holoenzyme complex. Induction of alternative splicing variants that lack catalytic activity.

03

Biological functions

Maintenance of telomere lengthChromosome end replication and protectionCellular senescence regulationCell proliferation controlGenomic stability preservation
04

Disease associations

Cancer (overexpression/activation in most cancers)Aging and cellular senescence (repression leads to telomere shortening)Genetic disorders such as Cri du chat syndrome (absence or mutation)
05

Safety considerations

Potential effects on normal stem cells and progenitor cells that require low-level telomerase activity for tissue maintenanceRisk for impaired wound healing, hematopoietic dysfunction, or accelerated aging phenotypes with systemic inhibition
06

Interacting drugs

Imetelstat (GRN163L, a direct telomerase inhibitor)

2 more in the full profile.

07

Biomarkers

hTERT mRNA expression levels in tumor tissueTelomere length measurements in blood or tissue samples

Beyond the preview

Go deeper on Telomerase reverse transcriptase (TERT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomerase reverse transcriptase (TERT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call